approval · primary record
RAVULIZUMAB-CWVZ
FDA · BLA · 2026-10-23
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-10-23 |
| Brand | ULTOMIRIS |
| Sponsor | ALEXION PHARM |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:37.475Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:RAVULIZUMAB-CWVZ:2026-10-23
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.